The Board of Directors of Suven Life Sciences Limited at its meeting held today i.e. 28th March, 2022 has approved the conversion of 1,81,00,000 fully paid warrants and issued & allotted 1,81,00,000 (One crore eighty one lakh) Equity Shares of Rs.1/- each to "Jasti Property and Equity Holdings Private Limited (In its capacity as sole trustee of Jasti Family Trust)", promoter group entity at an issue price of Rs. 81.57/- per share on preferential basis in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.
The Company has received from allottee i.e. Jasti Property and Equity Holdings Private Limited (In its capacity as sole trustee of Jasti Family Trust)total consideration amount of a preferential issue aggregating to Rs. 147,64,17,000/- within a period of 18 months from the date of allotment of convertible warrants.
Consequently, the paid-up equity share capital of the company stands increased from 127282478 (Rs. 12,72,82,478.00) equity shares to 145382478 (Rs. 14,53,82,478.00) equity shares.
Shares of Suven Life Sciences Limited was last trading in BSE at Rs. 86.15 as compared to the previous close of Rs. 92.10. The total number of shares traded during the day was 94428 in over 1520 trades.
The stock hit an intraday high of Rs. 92.25 and intraday low of 85.65. The net turnover during the day was Rs. 8331701.00.